APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis
about
MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's diseaseProtein phosphatases and Alzheimer's diseaseToward more predictive genetic mouse models of Alzheimer's diseaseDissecting Alzheimer disease in Down syndrome using mouse modelsThe Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeletonNeuropathological alterations in Alzheimer diseaseLoss of Polo ameliorates APP-induced Alzheimer's disease-like symptoms in DrosophilaNeurodegenerative disease and adult neurogenesisThe Psen1-L166P-knock-in mutation leads to amyloid deposition in human wild-type amyloid precursor protein YAC transgenic mice.Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer.Impaired structural correlates of memory in Alzheimer's disease mice.A review of β-amyloid neuroimaging in Alzheimer's disease.Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice.The neurovascular unit in brain function and disease.Comparative transcriptome profiling of amyloid precursor protein family members in the adult cortexMolecular mechanisms of neurodegeneration in Alzheimer's disease.Neurotoxicity of cancer chemotherapy.Knockdown of amyloid precursor protein in zebrafish causes defects in motor axon outgrowth.Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10.Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesisThe pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.Temporal profiles of synaptic plasticity-related signals in adult mouse hippocampus with methotrexate treatment.CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.The use of mouse models for understanding the biology of down syndrome and agingStereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus.Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's diseaseTurmeric and curcumin suppress presenilin 1 protein expression in Jurkat cellsAbca7 deletion does not affect adult neurogenesis in the mouse.Generation of a novel murine model of Aβ deposition based on the expression of human wild-type amyloid precursor protein gene.LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of NutraceuticalsFluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer's Disease.Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function.The multiplicity of action of cannabinoids: implications for treating neurodegeneration.Neurogenesis in Alzheimer's disease.Modeling human neurodegenerative diseases in transgenic systems.The influence of cannabinoids on generic traits of neurodegeneration.Cognitive reserve and Alzheimer's disease.Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism.Adult neurogenesis in neurodegenerative diseases.Tau-dependent suppression of adult neurogenesis in the stressed hippocampus.
P2860
Q24616286-74526DFD-D437-4B6A-BDFB-A31B04AE26DDQ24632495-821FF6F8-F741-4734-AB0B-974F4E599898Q26771883-102EF6EC-D778-44F8-9C9D-0F30022440C5Q26777254-5CD2DCB3-D266-4072-A0A8-0CE8C234B301Q26864818-F9626431-46DA-45C2-BBEE-0EE9AE4B79AAQ27003314-91592D37-2A70-4D6E-B8FB-26EB0222606EQ27305748-02B70D87-6175-452F-A52D-44F8EEC73D33Q28307113-8A012433-5B79-4BDA-926A-E634E22C42A3Q30418483-6C10C05D-6FA5-4D5C-855C-FECC294E3392Q30497879-FB1AA6EC-40ED-4950-A1A2-6636C07CA1FCQ30701096-66292E50-D589-4C9B-8460-3578EF01C72FQ30870063-04CA6900-B62E-44ED-97A1-C56E0EC5616EQ33709399-4A277921-F1AF-4A72-8754-C92197AA244BQ33805295-772361BB-01FF-4CDF-8AEA-F2F33CE8EC8BQ33854917-5D252C6C-0959-4AE2-8D97-DD36B2591113Q33871297-8D6C726F-3BFE-4ECB-AF79-E378F75CEBB2Q34094753-D047131D-BABA-41BC-A518-0AACA23003EDQ34251023-7DCBCA7E-8AD7-452C-9878-A8D7A09BF8CFQ34272420-71887314-619B-4FA7-AAFF-6AC04F1EBA99Q34299878-31C9F157-7600-4824-ACBC-3DACBDC9AA21Q34512696-293063D5-A77E-4E08-9739-89A51666F1E1Q35020774-146E5E01-7B11-4276-9BDA-D571E1D993AEQ35034581-F6AE73EF-BC88-4BD2-8B45-D18E280486DBQ35810481-18C1803D-BBD5-4A6C-ABF2-C95B534482DAQ35983214-9BE78F17-E604-408C-8C96-89DC573790B5Q36196728-1C4CA808-E4BB-460C-809F-329FF19AA5A9Q36230611-CE99DA18-EDED-4ACD-AC2F-83C153B50FF2Q36691233-A1D60CC0-A0A0-49D2-B63A-0C1DF3A43F73Q36719050-8E6B493C-40B4-4242-8F95-D96E51CB4657Q36781712-3F32A580-BE83-4A9E-BCB0-9C593228D016Q37386143-49CB1C99-BF27-4CBF-B7D4-2A5F671F463BQ37554021-6E58DA3E-D93C-4820-8156-D9DE916265F0Q37793366-6D927237-83FD-4AB7-B2D3-B6226DBD065AQ37842603-EABDF7C5-E285-4C9E-B969-13434C7264BCQ37968206-22D6AF63-6895-4CC6-9D16-4725CCD50811Q38156518-5EF63B60-B3DA-4277-88A0-65F277ED2DDFQ38209190-1545AB50-62A0-455F-B9C0-52AFF1329D80Q38368300-0F83192D-1325-4F82-8449-B50FDE5E66E1Q38400868-12204F03-B4AD-45D6-9BBF-04B18CE1096FQ38758004-0E7F09DE-1A23-4B07-9A44-F182196497F7
P2860
APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
APP transgenic modeling of Alz ...... tion and aberrant neurogenesis
@ast
APP transgenic modeling of Alz ...... tion and aberrant neurogenesis
@en
type
label
APP transgenic modeling of Alz ...... tion and aberrant neurogenesis
@ast
APP transgenic modeling of Alz ...... tion and aberrant neurogenesis
@en
prefLabel
APP transgenic modeling of Alz ...... tion and aberrant neurogenesis
@ast
APP transgenic modeling of Alz ...... tion and aberrant neurogenesis
@en
P2860
P921
P1476
APP transgenic modeling of Alz ...... tion and aberrant neurogenesis
@en
P2093
Leslie Crews
P2860
P304
P356
10.1007/S00429-009-0232-6
P577
2009-11-29T00:00:00Z
2010-03-01T00:00:00Z